The Global Lipid Market size is expected to reach $12.8 billion by 2028, rising at a market growth of 8.3% CAGR during the forecast period – Yahoo Finance

Nutritional lipids are fats that provide the body with energy-dense calories. They are the most sought-after nutrients nowadays. Consumption of nutritional lipids has increased as individuals become more aware of the benefits of a healthy fat diet and demand for lipid-containing food supplements rises.
New York, June 29, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Lipid Market Size, Share & Industry Trends Analysis Report By Application, By Source, By Regional Outlook and Forecast, 2022 – 2028” – https://www.reportlinker.com/p06289266/?utm_source=GNW
The need to meet the nutritional needs of the aging population, the rise in the prevalence of chronic diseases, the surge in the use of infant formulas and dietary supplements, the rise in the obese population, and technological advancements are all driving the nutritional lipid market.

Reduced inflammation, cardiac stability, and low-density lipoprotein decrease are all health benefits of consuming nutritional lipids. These reasons are propelling the nutritional lipids market forward. Since the human body is incapable of producing omega-3 and omega-6 fatty acids, people are more likely to consume nutritional lipids to control nutritional insufficiency. The market for nutritional lipids grows as a result of these causes.

Over the next few years, the market is anticipated to rise due to rising demand for lipids as a nutritional supplement, growing awareness among customers to enhance their health, and changing food patterns due to busy lifestyles. Furthermore, the product plays a crucial role in the treatment of chronic diseases such as arthritis, asthma, cystic fibrosis, cancer, and diabetes, which is projected to drive the market and experience a significant rise over the upcoming period.

Lipids are organic molecules that are produced as byproducts of the production of fatty acids and related compounds in both plants and animals. They’re used in food and beverage, nutrition and supplements, pharmaceuticals, animal nutrition, and the personal care business, among other things. Governments in the United States, the United Kingdom, Germany, and Australia, on the other hand, have published guidelines for the manufacture and sale of lipid products. For example, in the United States, the Food and Drug Administration (FDA) developed guidelines for creating lipid products.

COVID-19 Impact

The demand for lipid-based supplements has increased significantly as a result of the COVID-19 pandemic, owing to their health-promoting qualities. In addition, Moderna Inc, a pharmaceutical company based in the United States, has extended a contract with Corden Pharma to protect large amounts of lipids and use them to make their trial COVID-19 vaccine in order to meet the growing demand for the vaccine. Since novel lipids have shown remarkable potential for medical and nutritional applications in recent years, the market for novel lipids is expected to rise over the upcoming period.

Market Growth Factors

Lipid Required for a Healthy Diet

A balanced diet can help prevent malnutrition and non-communicable diseases like diabetes, heart disease, and cancer. For appropriate metabolism and physiological functionality, lipids must be included in the daily diet. The nutritional lipid is made up of several types of fats that have specific benefits and functions in the human body. The nutrition lipid is made up of several types of fats that have specific benefits and functions in the human body. Nutrition lipid is also utilized in animal feed and pet food formulae to increase the amount of lipid in livestock, and improve their health.

Rising Incidence of Chronic Diseases Use of Lipid in By the Cosmetic Industry

The need for lipid-based medication delivery systems is increasing due to the rise in chronic and lifestyle-related disorders. Expanding production capacities for medicinal lipids is helping lipids companies build solid revenue streams. Manufacturers are diversifying the production of useful lipids like omega-3, phytosterols, and conjugated linoleic acids, which aid in bone, blood pressure, and cardiovascular health management. Carotenoids and a variety of other chemicals are frequently employed as bioactive additives in a variety of food products.

Market Restraining Factors

Over Consumption of Lipids Can Cause Health Issues In Some Consumers

While lipids are necessary for good health and the maintenance of life, eating too much can put one in danger of developing liver and heart problems. In the United States and around the world, cardiovascular illnesses are the leading cause of death. According to the World Health Organization, 17.9 million people die each year from cardiovascular disease. A buildup of low-density lipoprotein (LDL) can induce atherosclerosis, which can result in a heart attack or stroke. High levels of LDL can be avoided by controlling cholesterol and saturated fat intake and increasing HDL levels. Diets high in fast food, fatty meat, deep-fried foods, cheese, milk, yogurt, butter, and processed foods have been related to high LDL levels.

Application Outlook

Based on Application, the market is segmented into Food & Beverages, Pharmaceuticals, Nutrition & Supplements, and Others. The pharmaceutical segment garnered a substantial revenue share in the lipid market in 2021. Lipids and polymers are considered fundamental excipients in pharmaceutical technology for the production of most dosage forms, regardless of delivery mode. They provide a variety of functions, including support vehicles, stabilizers, solubilizers, permeation enhancers, and transfection agents.

Source Outlook

Based on Source, the market is segmented into Plant-based and Animal-based. Plant-based lipids are anti-inflammatory, preventing artery hardening, relieving muscular pain, and improving the physical conditions of the brain, cardiac, and other body parts that have become inflamed, bloated, hot, and painful as a result of a reaction or infection. As a result, the plant-based category is likely to make a substantial contribution to the market

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. Asia Pacific acquired the largest revenue share in the lipid market in 2021. China and India are making a favorable impact on the market. This is due to the rising demand for nutraceutical products and the region’s growing pharmaceutical industry. The market is also being driven by a growing population, quickly changing lifestyles, business-friendly government policies, and big company investments. Due to the growing need for lipids in the nutraceutical sector, India is likely to have a high demand for lipid in the upcoming years.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Archer Daniels Midland Company, BASF SE, Koninklijke DSM N.V., Reckitt Benckiser Group PLC, Kerry Group PLC, Clover Corporation Limited, Croda International PLC, FMC Corporation, Cargill Corporation, and Nordic Naturals, Inc.

Strategies deployed in Lipid Market

Nov-2021: Archer Daniels Midland acquired Deerland Probiotics & Enzymes, a Kennesaw, Georgia-based global provider of dietary supplements using probiotic, prebiotic, and enzyme technology. The acquisition helped ADM solidify its innovation leadership in dietary supplements and functional foods, and assist it in serving customers around the globe.

Jul-2020: Croda International completed the acquisition of Avanti Polar Lipids, a biotechnology company. The acquisition integrated Avanti’s expertise in lipid-based drug delivery solutions through its research products and pharmaceutical services with Croda’s range of life science products and cGMP manufacturing capacities to increase their respective range of products and services for biotechnology businesses, academic institutions, and pharmaceutical companies globally.

May-2020: DSM released DHA SF55-O200DS, high-quality oil for maternal and early life nutrition solutions. This product was the only 550 mg/g natural triglyceride DHA developed for use in maternal nutrition and was designed for women who are planning to conceive, are pregnant, breastfeeding, or non-breastfeeding post-natal mothers.

Apr-2020: DSM launched DHASCO-B and ARASCO powders, two new high-quality lipid powders for infant nutrition. The two powders contain a minimum of 110 mg/g of DHA (docosahexaenoic acid) or ARA (arachidonic acid) respectively. These powders were designed to aid optimal growth and development during early life, and allow producers to meet the recent expert recommendation for adding both DHA and ARA to infant and follow-on formula.

Dec-2019: BASF released Hepacor, an omega-3 fatty acid product. The product was launched in Switzerland, BASF’s first market in continental Europe, to help patients manage Non-Alcoholic Fatty Liver Disease (NAFLD). The release of Hepacor in Switzerland marks a major milestone in BASF’s plans to commercialize a targeted solution for NAFLD management worldwide.

Jun-2018: BASF entered into an agreement with Xerion, an Australian-based specialty pharmaceutical company. As per the agreement, BASF’s human nutrition brand, Newtrition, received exclusive distribution rights to market PUFAcoatTM Omega-3 Index test kits, Xerion’s proprietary dried blood spot technology.

Apr-2018: Archer Daniels Midland Company released Versity, a new alternative protein source for pets. The product was released through a division of Archer Daniels Midland Company called ADM Animal Nutrition. Versity has an amino acid profile similar to an egg, but at a more affordable price, making it a perfect complementary or replacement protein source for dogs and cats.

Scope of the Study

Market Segments covered in the Report:

By Application

• Food & Beverages

• Pharmaceuticals

• Nutrition & Supplements

• Others

By Source

• Plant-based

• Animal-based

By Geography

• North America

o US

o Canada

o Mexico

o Rest of North America

• Europe

o Germany

o UK

o France

o Russia

o Spain

o Italy

o Rest of Europe

• Asia Pacific

o China

o Japan

o India

o South Korea

o Singapore

o Malaysia

o Rest of Asia Pacific

• LAMEA

o Brazil

o Argentina

o UAE

o Saudi Arabia

o South Africa

o Nigeria

o Rest of LAMEA

Companies Profiled

• Archer Daniels Midland Company

• BASF SE

• Koninklijke DSM N.V.

• Reckitt Benckiser Group PLC

• Kerry Group PLC

• Clover Corporation Limited

• Croda International PLC

• FMC Corporation

• Cargill Corporation

• Nordic Naturals, Inc.

Unique Offerings

• Exhaustive coverage

• Highest number of market tables and figures

• Subscription based model available

• Guaranteed best price

• Assured post sales research support with 10% customization free
Read the full report: https://www.reportlinker.com/p06289266/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

Yahoo Finance Live's Seana Smith takes a look at Micron's stock following a slump in Q4 revenue guidance.
The super investor still sees opportunities ahead.
Memory-chip maker Micron Technology badly missed estimates with its guidance for the current quarter. MU stock fell on the news.
(Bloomberg) — Enjoy Technology Inc., a retail startup founded by former Apple Inc. executive Ron Johnson, filed for bankruptcy on Thursday — less than a year after going public through a merger with a blank-check company.Most Read from BloombergStock Doomsayers Vindicated in Historic First Half: Markets WrapThe Wheels Have Come Off Electric VehiclesDemocrats Weigh Paring Biden Tax Hike to Win Over ManchinSupreme Court Crimps Biden’s Climate Agenda With Limits on EPAUS Will Face High Gas Prices
What to watch in markets on Thursday, June 30, 2022.
The current market conditions – the NASDAQ is down 29% year-to-date, and the S&P 500 is down 21% – offer bargain hunters a target-rich environment. Plenty of sound stocks have seen their prices decline, pulled down by the general market headwinds and the overall stock trend, to levels that have left them too cheap to ignore. At this level, investors can find the benefits of cheap stocks, which offer both learning opportunities and strong upside potential. However, in evaluating stocks to buy, it
Shares of Amazon (NASDAQ: AMZN), Apple (NASDAQ: AAPL), and Nvidia (NASDAQ: NVDA) were all falling this morning after the Commerce Department reported its latest inflation figures, which showed inflation remains persistently high. The report said that the core personal consumption expenditures index rose 4.7% in May, only slightly less than expected and still a four-decade high. Technology investors have been watching inflation figures very closely, and with today's report, Amazon plunged 3.5%, Apple fell 2.4%, and Nvidia dropped 2.2%.
Shares of Dutch Bros (NYSE: BROS) were tasting like a day-old cup of coffee in morning trading, with the stock falling 7.2% at 11:25 a.m. ET Thursday, though there was no company-specific news to drive the movement. The drive-thru coffee shop's stock fell sharply after the company released its earnings report in May over concern about inflation's impact on its business. Over a quarter of the coffee slinger's shares outstanding are sold short as of the latest report in June, and meme-stock traders are known to favor such situations in hopes of triggering a short squeeze by piling into the stock.
In this article, we discuss Cathie Wood’s latest thoughts on inflation and her 10 worst-performing stock picks. If you want to read about some more stocks in the Wood portfolio, go directly to Cathie Wood’s Latest Thoughts on Inflation and Her 5 Worst-Performing Stock Picks. Cathie Wood of ARK Investment Management has come under fire […]
Memory-chip maker Micron said fiscal-fourth-quarter results will come up short. Demand for PCs and smartphones is softening, and could hurt prices for DRAM and NAND chips.
Advanced Micro Devices is declining to new 52-week lows and is now down 54% from its all-time high just just seven months ago. For now, Micron's earnings report after the close remains a bit of a wildcard for semi-stock investors, as it sits on a critical support level. Regarding AMD stock specifically, the valuation has been pummeled, as the stock price has been more than halved while earnings estimates remain steady — at least so far.
In this article, we will be taking a look at 10 extreme dividend stocks with upside potential. To skip our detailed analysis of dividend investing, you can go directly to see the 5 Extreme Dividend Stocks with Upside Potential. Dividend investing has been an attractive prospect for individual investors and hedge funds alike for many years. […]
Nio (NYSE: NIO) stock is down this week after a short-seller attack. In Nio's case, Grizzly Research alleges the electric vehicle (EV) manufacturer used an "audacious scheme" to inflate its revenue and profitability, even likening it to the Valeant Pharmaceuticals scandal in which the company was found guilty of using related-party transactions to boost sales. The third party that Grizzly Research is referring to is linked to Nio's popular battery program, which is a major competitive advantage.
A bear market leaves the S&P 500 with its worst first six months since 1970. Here's what's happened after stocks suffered steep first-half stumbles in the past.
The semiconductor sector has lost more than one-third of its value this year, but a BofA Global Research analyst says the pain isn't over for investors.
Despite current and legacy problems, it remains a robust company paying a high and reliable dividend
Camelot loses legal battle to keep hold of National Lottery A defence spending cut – disguised by Boris Johnson's fiscal sleight of hand FTSE 100 falls 0.8pc as recession fears return Ben Marlow: Heathrow risks killing off the golden age of air travel Sign up here for our daily business briefing newsletter
Memory-chip maker Micron Technology issued a subdued revenue outlook, spooking investors even as it reported a strong rise in earnings for its latest quarter. “Recently, the industry demand environment has weakened, and we are taking action to moderate our supply growth” in coming quarters, Chief Executive said in a statement, adding that he was still confident about long-term demand for memory and storage. Micron which makes data-storage and memory chips for computers and smartphones, had enjoyed a major upswing in sales and profit during the pandemic, benefiting from surging demand for electronics amid the work-from-home shift.
These income stocks, with yields ranging from 4.5% to 12.5%, are ripe for the picking with the Nasdaq plunging up to 34%.
Despite Tesla CEO Elon Musk warning employees of an “insane end-of-quarter delivery push,” Wall Street sell-side analysts are still taking down their second quarter delivery estimates, only days before Tesla’s Q2 delivery and production report will come out.

source